Literature DB >> 7696015

Is thrombolytic therapy in acute inferior myocardial infarction really better than conventional treatment?

T J Tobé1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7696015      PMCID： PMC483772          DOI： 10.1136/hrt.73.2.108

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  12 in total

1.  Quantitative study on the size of coronary artery supplying areas postmortem.

Authors:  H Kalbfleisch; W Hort
Journal:  Am Heart J       Date:  1977-08       Impact factor: 4.749

2.  A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty.

Authors:  A D Guerci; G Gerstenblith; J A Brinker; N C Chandra; S O Gottlieb; R D Bahr; J L Weiss; E P Shapiro; J T Flaherty; D E Bush
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

Review 3.  Thrombolytic reperfusion of acute myocardial infarction: resolved and unresolved issues.

Authors:  E Braunwald
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

4.  Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarction.

Authors:  J P Bassand; R Faivre; O Becque; C Habert; M Schuffenecker; P Y Petiteau; J C Cardot; J Verdenet; M LaRoze; J P Maurat
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

5.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; J A Ormiston; T Whitlock
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

6.  Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: the Western Washington Randomized Intracoronary Streptokinase Trial.

Authors:  M L Stadius; C Maynard; J K Fritz; K Davis; J L Ritchie; F Sheehan; J W Kennedy
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

7.  Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group.

Authors:  P Rossi; L Bolognese
Journal:  Am J Cardiol       Date:  1991-09-01       Impact factor: 2.778

8.  Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.

Authors:  J P Bassand; J Machecourt; J Cassagnes; T Anguenot; R Lusson; E Borel; P Peycelon; E Wolf; D Ducellier
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function.

Authors:  G V Martin; F H Sheehan; M Stadius; C Maynard; K B Davis; J L Ritchie; J W Kennedy
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
View more
  5 in total

1.  Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction.

Authors:  K Schröder; K Wegscheider; K L Neuhaus; U Tebbe; R Schröder
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Management of acute myocardial infarction.

Authors:  M Turner
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

3.  Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction?

Authors:  H S Lee
Journal:  Br Heart J       Date:  1995-10

4.  Ejection fraction and mortality rate of patients with isolated acute inferior myocardial infarction reperfused by streptokinase.

Authors:  Mozhdeh Beiraghdar; Zahra Pourmoghaddas; Mohammad Reza Torknezhad; Ali Torkan
Journal:  ARYA Atheroscler       Date:  2011

Review 5.  Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?

Authors:  Yochai Birnbaum; Glenn N Levine; John French; Juan Carlos Kaski; Dan Atar; Mahboob Alam; David Hasdai; Hani Jneid; Barry F Uretsky
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-15       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.